Study S001060

Comparative Effects of Antidiabetic Medications on Postprandial Hyperlipidemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals With Prediabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02104739
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 21
Start: 2014-04
Primary completion: 2017-03
Lead sponsor: The University of Texas Health Science Center, Houston
Conditions: Prediabetes; Obesity
Interventions: DRUG:Exenatide; DRUG:Saxagliptin; DRUG:Exenatide extended-release (ER); OTHER:Placebo
Results posted: TRUE

Registered primary outcomes

Monocyte NfkB Levels as Detected by Western Blotting [baseline]
Monocyte NfkB Levels as Detected by Western Blotting [2 hours after ingestion of meal]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0019428	Acute Exenatide Therapy Attenuates Postprandial Vasodilation in Humans with Prediabetes: A Randomized Controlled Trial. Hamidi V, Metabolic syndrome and related disorders	2020	Randomized trial	PMID 32228379 DOI	cites ClinicalTrials.gov:NCT02104739; registry reference DERIVED:32228379